Sell ANTHROPIC by Nov 16, 2026.

Recent reports indicate that Anthropic's valuation could be down a third from its peak just two months ago as DeepSeek and Kimi are rapidly closing the performance gap at a fraction of the cost. Anthropic is likely spending continuously into falling prices with a product that gets commoditized in a few quarters before it's paid for. That's pharma without patent protection, and nobody pays high valuation multiples for pharma without patents. If frontier models are commoditizing this quickly, how much …